Evaluation of the clinical use of PET/CT with 68Ga-PSMA for the assessment of biochemical recurrence of low or intermediate-risk prostate cancer.
CONCLUSION: PET-PSMA is useful for the assessment of biochemical recurrence in prostate cancer patients with prostate cancer at low and intermediate-risk.
PMID: 32861620 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Ribeiro AMB, Lima ENP, Zequi SC Tags: Urol Oncol Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | PET Scan | Prostate Cancer | Study | Urology & Nephrology